sales@contrivedatuminsights.com
CDI - Contrive Datum Insights
Press ReleaseMedical Devices

Physiotherapy Equipment Market to Reach USD 37.9 billion by 2034 at 5.93% CAGR

35% of 2025 revenue sits in North America, and 10.62% growth in Shockwave Therapy Equipment leads the product type axis.

PUNE, INDIA — 8 OCTOBER 2026 — CONTRIVE DATUM INSIGHTS

Market reaches USD 37.9 billion by 2034, up from USD 22.6 billion in 2025, at a 5.93% CAGR.

North America holds 35% of 2025 revenue at USD 7.91 billion.

Shockwave Therapy Equipment is the fastest-growing line at 10.62% annually.

Exercise and Strength Therapy Equipment leads product type with 31.4% of 2025 revenue.

The global physiotherapy equipment market was valued at USD 22.6 billion in 2025. The market is projected to grow from USD 23.9 billion in 2026 to USD 37.9 billion by 2034, exhibiting a compound annual growth rate of 5.93% during the forecast period. Contrive Datum Insights presents this information in its report titled "Physiotherapy Equipment Market Size, Share & Industry Analysis, By Product type (Electrotherapy Equipment, Therapeutic Ultrasound Equipment, Shockwave Therapy Equipment, Laser and Light Therapy Equipment, Shortwave and Microwave Diathermy, Exercise and Strength Therapy Equipment, Traction Equipment, Thermotherapy and Cryotherapy Equipment, Hydrotherapy Equipment, Continuous Passive Motion Devices), Application (Musculoskeletal Disorders, Neurological Disorders, Cardiovascular and Pulmonary Rehabilitation, Sports Injuries, Post-Surgical and Orthopedic Rehabilitation, Pain Management, Pediatric Disorders, Women's Health and Pelvic Floor), End user (Hospitals, Physiotherapy Clinics, Rehabilitation Centers, Sports Clubs and Athletic Facilities, Home Care Settings, Nursing and Long-Term Care Facilities), Level of automation (Manual and Mechanical, Electrically Powered, Computer-Controlled and Software-Guided, Robotic and Exoskeleton-Assisted), Portability (Stationary and Floor-Standing, Portable and Handheld, Wearable), Treated body region (Upper Limb and Shoulder, Lower Limb, Spine and Trunk, Neck and Head, Pelvic Region, Full Body), Patient age group (Pediatric, Adult, Geriatric), Distribution channel (Direct Sales, Medical Equipment Distributors and Dealers, Online and E-commerce, Tender and Group Purchasing, Rental and Leasing), Revenue stream (Capital Equipment, Accessories and Consumables, Software and Digital Platforms, Installation, Service and Maintenance), and Regional Forecast, 2026-2034".

Physiotherapy equipment covers the devices used to restore movement, reduce pain and rebuild strength in patients with injury, disease or disability. It spans electrotherapy and ultrasound units, shockwave and laser systems, heat and cold devices, exercise and traction equipment, hydrotherapy installations and powered or robotic rehabilitation systems, supplied as stationary clinic units and as portable or wearable products. Buyers include hospitals, physiotherapy clinics, rehabilitation centres, sports facilities, long-term care homes and, increasingly, patients and carers treating at home.

Ageing populations and musculoskeletal disease burden

Ageing populations and musculoskeletal disease burden is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 5.93% a year, the product type lines exposed to it move fastest: Shockwave Therapy Equipment compounds at 10.62%, taking its share of revenue from 5.5% to 8.2% and its value from USD 1.243 billion to USD 3.108 billion.

A more favourable outcome is possible. If reimbursement for outpatient and home rehabilitation widens, robotic and wearable systems reach clinics faster, and Asia Pacific clinic capacity grows ahead of plan, 2034 revenue reaches USD 42.4 billion instead of the USD 37.9 billion the base case carries.

The downside is specific. Reimbursement tightens, clinic capital budgets stay constrained, and robotic and computer-guided systems stay limited to specialist centres, so volumes and prices both fall short of the base case, and 2034 revenue lands at USD 33.7 billion. Electrotherapy Equipment is the drag, 21% of the 2025 base compounding at 4.44% while the market runs at 5.93%.

The Competitive Split Runs by Product type

Two positions matter, and they are set by product type. Exercise and Strength Therapy Equipment carries 31.4% of 2025 revenue (USD 7.096 billion) and is still the largest line in 2034 at 36%, hard to take from an incumbent. Shockwave Therapy Equipment, at 10.62%, is where the USD 22.6 billion base is redistributed. The two demand different capabilities.

Additional Findings

SegmentLed 2025 byShare & valueFastest-growing
ApplicationMusculoskeletal Disorders38% · USD 8.588 billionWomen's Health and Pelvic Floor 10.62%
End userPhysiotherapy Clinics33% · USD 7.458 billionHome Care Settings 11.16%
Level of automationElectrically Powered52% · USD 11.752 billionRobotic and Exoskeleton-Assisted 14.39%
PortabilityStationary and Floor-Standing62% · USD 14.012 billionWearable 13.06%
Treated body regionLower Limb28% · USD 6.328 billionPelvic Region 9.95%
Patient age groupAdult55% · USD 12.43 billionGeriatric 8.08%
Distribution channelDirect Sales40% · USD 9.04 billionRental and Leasing 12.7%
Revenue streamCapital Equipment68% · USD 15.368 billionSoftware and Digital Platforms 15.9%
  • North America was the largest region in 2025, holding 35% of global revenue at USD 7.91 billion and reaching USD 11.9 billion by 2034.
  • Asia Pacific takes a rising share of global revenue over the forecast period, from 25% in 2025 to 31.3% in 2034, with revenue growing from USD 5.65 billion to USD 11.863 billion.
  • Middle East and Africa stays the smallest contributor across the period: 6% of revenue in 2025 and 6% in 2034.
  • By product type, the largest line in 2025 was Exercise and Strength Therapy Equipment, at 31.4% of revenue and USD 7.096 billion.
  • Shockwave Therapy Equipment is projected to grow at 10.62% over the forecast period, the fastest of any product type line.
  • The United States is the largest single country market at USD 6.95 billion in 2025, 30.75% of global revenue.

The study covers nine axes, by product type, and by application, end user, level of automation, portability, treated body region, patient age group, distribution channel and revenue stream, reporting revenue and a growth rate for every line in every year from 2020 to 2034, with bear, base and bull scenarios on the headline total at USD 33.7 billion and USD 42.4 billion by 2034. Country-level detail is given for all five regions, together with the competitive landscape and the research methodology. Delivered as a PDF; request a free sample to review it.

Regions Covered
North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa
About Contrive Datum Insights

Contrive Datum Insights is a global market intelligence and consulting firm working across investment, information technology, healthcare and manufacturing markets. Every market we publish is sized twice — once top-down from the leading players and once bottom-up from the addressable base — and validated by primary interview. More about CDI.

Asia Pacific
Kunjir Shyama Prestine, Sr. no. 174/1
Jagtap Diary Road, Pimple Saudagar
Pune 411017, India
+91 983 481 6757
United States
21C2 Lakeshore Dr.
Farmington, CT 06032
United States
+1 215 297 4078